Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06586853
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-24
Brief Title:
Outcome and Complications of Regular Hemodialysis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Assessment of Complications and Outcome of Regular Hemodialysis Patients in Upper Egypt Two Center Prospective Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assessment of the major hemodialysis outcomes which are vascular access events mortality and hospitalization Quality of life in end stage renal disease ESRD patients undergoing regular hemodialysis in upper Egypt and analysis of the major hemodialysis outcomes along a one year duration
Detailed Description:
Regular dialysis treatment has been available at a national level in Egypt for more than three decades Hemodialysis is a vital and lifesaving procedure so that many organizations including governmental and non-governmental bodies adopt it Hemodialysis service is usually provided by either non-profit- or profit-based bodies
Dialysis therapy ameliorates many of the clinical manifestations of renal failure and postpones otherwise imminent death Despite this undeniable success hemodialysis patients have higher mortality and hospitalization rates and lower quality of life than the general population Also patients must contend with unique treatment complications such as vascular access failure at considerable expense and morbidity
Effective hemodialysis requires repeated and reliable access to the bloodstream through a central venous catheter or a surgically created arteriovenous communication an autologous fistula or a synthetic graft However vascular access thrombosis and infection occur frequently and are the leading cause of dialysis-related morbidity
Mortality in hemodialysis patients The greatest number of deaths were due to infections followed by withdrawal from dialysis cardiac sudden death vascular and other
Quality of life in hemodialysis patients is reduced in all the health domains of Hemodialysis patients Older age male gender unemployment and duration of dialysis adversely affected the QOL scores
Hospitalization in hemodialysis Patients with end-stage kidney disease ESKD have a greater risk of comorbidities including diabetes and anemia and have higher hospital admission rates than patients with other diseases The cause of hospital admissions is associated with end-stage kidney disease ESKD prognosis
Dialysis therapy ameliorates many of the clinical manifestations of renal failure and postpones otherwise imminent death Despite this undeniable success hemodialysis patients have higher mortality and hospitalization rates and lower quality of life than the general population Also patients must contend with unique treatment complications such as vascular access failure at considerable expense and morbidity
Effective hemodialysis requires repeated and reliable access to the bloodstream through a central venous catheter or a surgically created arteriovenous communication an autologous fistula or a synthetic graft However vascular access thrombosis and infection occur frequently and are the leading cause of dialysis-related morbidity
Mortality in hemodialysis patients The greatest number of deaths were due to infections followed by withdrawal from dialysis cardiac sudden death vascular and other
Quality of life in hemodialysis patients is reduced in all the health domains of Hemodialysis patients Older age male gender unemployment and duration of dialysis adversely affected the QOL scores
Hospitalization in hemodialysis Patients with end-stage kidney disease ESKD have a greater risk of comorbidities including diabetes and anemia and have higher hospital admission rates than patients with other diseases The cause of hospital admissions is associated with end-stage kidney disease ESKD prognosis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None